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Background: Establishing methods for secure long term storage of RNA is critical to realizing the promise of
biobanks in biomedical research. Here, we describe the results of yearly analyses of the same set of umbilical cord
and adult whole blood RNA collected in Tempus Blood RNA tubes and stored at −80°C, over a period of up to six
years. We systematically investigated the effects of long-term storage of samples (75 Tempus tubes form three adult
donors and 30 Tempus tubes from three cord blood donors) on the RNA quality and transcript stability of six
selected genes (CDKN1A, FOS, IL1B, IL8, MYC and TP53). This is the first systematic study of both cord and adult
blood samples stored for many years.
Findings: The RNA purity and integrity, expressed as RIN-values, were stable up to six years of storage, and there
were no storage-related deleterious effects on RNA purity. There were limited intra- and inter-individual variations in
RNA yields; however, no consistent trend of decreasing RNA yield was observed with the duration of storage. Some
long-term storage effects were found on the relative transcript levels of the six genes when compared to the year
0 samples. However, these changes were within ± 2–fold for both types of blood samples, except for two genes.
Our results show that storage of these samples for up to six years did not have significant effects on the RNA
quality and transcript stability of the six genes.
Conclusions: Blood RNA is stable in Tempus tubes stored at −80°C over a period of six years. Intact and
good-quality RNA suitable for transcript profiling analyses in epidemiological studies was obtained from blood
samples stored in Tempus tubes. This suggests that blood samples collected in large biobanks–such as the Mother
and Child (MoBa) Cohort at Norwegian Institute of Public Health (NIPH) and frozen in suitable collection tubes for
total RNA stabilization, can be used for quantitative studies after at least six years of storage.
Keywords: Tempus tubes, Cord blood, Long-term storage, Quality control, RNA stabilization, BiobankFindings
Background
The Mother and Child (MoBa) is a cohort consisting of
more than 114,000 pregnancies recruited between 1999
and 2008 [1]. In addition to detailed questionnaire data,
biological materials from the mother, the father and the
child (umbilical cord blood) in the form of whole blood
and plasma have been collected and are stored together* Correspondence: nur.duale@fhi.no
1The Norwegian Institute of Public Health, PO Box 4404, Nydalen, NO-0403,
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unless otherwise stated.with extracted DNA in a biobank at the Norwegian In-
stitute of Public Health (NIPH) for future use [2].
In 2005, the collection of umbilical cord blood RNA
was started as part of the Autism Birth Cohort (ABC)
study with support from the National Institute of Neuro-
logical Disorders and Stroke (NINDS). The ABC was
established to address the natural history of autism
spectrum disorders (ASD), explore genetic and pre- or
perinatal environmental factors in causation, as well as the
interplay between genes and environment, and to facilitate
discovery of biomarkers with the potential to enable early
recognition and treatment. The ASD cases in the ABCtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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MoBa, the cord blood was collected in Tempus Blood
RNA tubes [4], which contain stabilizing reagents that
preserve RNA transcripts [5]. Samples from hospitals and
maternity units all over Norway were transported by
standard mail (or by car for shorter distances) to the
MoBa Biobank at NIPH in Oslo for storage [4]. There are
several reports on ex vivo instability of RNA transcripts
that may take place during sample collection, transport,
storage and RNA extraction [6-8]. Although high-quality
RNA can be prepared using fresh blood that is processed
immediately, this option is hardly realistic when sampling
for a large-scale biobank where the blood samples are col-
lected in remote locations. Therefore, it is critical to re-
duce the impact of pre-analytical sample handling on
RNA quality and stability by stabilizing blood RNA prior
to shipping and RNA extraction. This is particularly im-
portant when collecting blood samples for large-scale bio-
banks, where the associated costs are very high. The two
commercially available RNA stabilizing technologies PAX-
gene™ Blood RNA system (PreAnalytiX, QIAGEN/BD,
Hombrechtikon, Switzerland), and Tempus™ Blood RNA
system (Applied Biosystems, Foster City, CA), where
blood is drawn directly into a tube containing RNA stabil-
izing reagents, are attractive approaches for expression
profiling of whole blood due to the simple handling re-
quired at the blood collection site.
In MoBa, the Tempus Blood RNA system was selected
based on our recent study [4], and approximately 50,000
samples have been collected and stored at –80°C. It is
likely that these samples will be kept under these condi-
tions for several more years, whereas selected samples
will be processed for measuring gene transcript levels
in nested case-control studies. When the collection of
Tempus tubes in MoBa started, there were few data
available on the effects of long-term storage on RNA
quality. Knowing the ex vivo instability of RNA tran-
scripts [6-8], it is essential to evaluate the quality of
RNA obtained from the stored samples, in the context
of potential use in downstream transcriptional profiling
studies.
Since this quality control (QC) study would run over
several years, probably involving different personnel and
different batches of kits, it was important to establish a
flexible protocol that was easy to follow but detailed
enough to correctly assess factors of importance for gene
expression analyses. Here we present the design and re-
sults of a QC study to evaluate the effects of long-term
storage on blood RNA quality.
Results and discussion
The NIPH MoBa Biobank was established to collect and
curate a wide range of biological samples for future use.
RNA is amongst the most labile of biological molecules.We designed and performed a QC study with adult and
cord blood RNA to assess the quality of the collected
samples over a six year period. Other studies have re-
ported the quality and gene transcript stability of whole
blood RNA collected from Tempus tubes [4,5,9,10], but
the present report is the first systematic evaluation of
long-term storage effects in such samples including both
cord and adult blood.
To determine the effects of long-term storage on RNA
quality and yield, Tempus Blood RNA samples were
taken out of the –80°C storage and total RNA was iso-
lated from each sample, at 0, 1, 2, 4 and 6 years. For
each time point (year), 15 Tempus tubes containing
adult blood from the same three donors (5 × 3) and six
Tempus tubes containing cord blood from three donors
(2 × 3) were analyzed for total RNA yield by spectro-
scopic quantitation, RNA integrity and purity by RIN
and OD measurement, and specific transcript stability
by real-time qPCR analysis for six cellular genes.
The total RNA yield, as analyzed by NanoDrop™ Spec-
trophotometer, was 7.3 ± 2.6 μg and 65.5 ± 20.4 μg per
Tempus tube, for the adult and cord blood samples, re-
spectively (Figure 1A and B). Consistent with our recent
report on effects of sample collection method and short
term storage of RNA samples [4], the yields in cord
blood samples were significantly higher than in the adult
blood samples (data not shown). This difference is likely
to reflect the higher cell content of the cord blood [11].
Limited intra- and inter-individual (donor) variations in
total RNA yields were observed, but the amounts of RNA
were sufficient for downstream gene expression analysis in
all adult and cord samples. Significantly lower RNA yields
than in years 0, 1 and 6 were recorded for cord blood sam-
ples analyzed at year 2 and 4 (Figure 1B). The reason for
this is unknown but the lower yields did not seem to be
related to the storage time. This may also be related to
the different batches of RNA extraction kits. The Tem-
pus tubes were from the same lot number, and all cord
blood samples were collected from the three donors on
the dates May 3rd, May 18th and May 19th (2005).
The integrity and purity of RNA can be used to evaluate
the effects of long-term storage on blood RNA. RNA with
an OD 260/280 ratio > 1.8 are generally accepted as pure
RNA suitable for gene expression analyses [12], and OD
260/230 ratio < 1.8 generally indicates the presence of con-
taminants. The OD 260/280 ratios for the samples were
within an acceptable range showing greater variation in
the adult than in the cord blood samples (Figure 2); how-
ever, there were no noticeable storage related deleterious
effects on RNA purity.
The effects of long-term storage on RNA integrity,
expressed as RIN-values, are shown in Figure 3. The
average RIN values for adult and cord blood samples
were 7.6 ± 0.5 and 7.7 ± 0.7, respectively. RIN values did
Figure 1 The effect of long-term storage on RNA yield. Adult (n = 75 Tempus tubes from 3 donors) and cord (n = 30 Tempus tubes from 3
donors) blood samples were collected in Tempus tubes (3 ml blood per tube) and stored at −80°C for up to six years, followed by total RNA
extraction. Each Tempus tube was considered as an independent biological sample. A) The RNA yield from the adult blood samples (n = 15
Tempus tubes/year). B) The RNA yield from cord blood samples (n = 6 Tempus tubes/year). Significantly lower RNA yields were recorded for cord
blood samples analyzed in year 2 and 4. The average total RNA yields for adult and cord blood samples were 7.3 ± 2.6 μg per Tempus tube and
65.5 ± 20.4 μg per Tempus tube, respectively. The RNA yields in cord blood samples were significantly higher than in the adult blood samples.
Each bar represents the average RNA yield and the error bar indicates ± SE.
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may range from 1 to 10 (RIN = 1; low RNA quality to
RIN = 10; highest RNA quality) [13]; RIN-values higher
than five imply an acceptable RNA quality, whereas
RIN-values above eight are considered ideal for down-
stream applications [7,8]. In this QC study, good-quality
RNA with average RIN values above seven was obtained
from both adult and cord blood samples. In our recent
study, we also obtained good-quality RNA from blood
samples collected in Tempus tubes [4]. Our results indi-
cate that the quality of RNA obtained from blood samples
were stable during storage, although some variability with
RIN values was recorded among donors as well as repli-
cate samples from the same donor.The RNA transcript stability in whole blood is reported
to be affected by ex vivo conditions such as the collection
procedure, shipment conditions, storage temperature and
duration [4,6,14]. In this study, the RNA transcript levels
for six selected genes (CDKN1A, FOS, IL1B, IL8, MYC and
TP53) were investigated by RT-qPCR and target genes were
normalized by 18S rRNA (internal control) (Figure 4A and
B). These genes were selected based on our recent study [4]
and literature search [15,16]. Storage of both adult and cord
blood samples at −80°C for up to six years was associated
with limited time- and sample-dependent changes in RNA
transcript stability. For both adult and cord blood samples,
an effect of storage was seen for the six genes when com-
pared to the year 0 samples and the effect was more
Figure 2 The effect of long-term storage on RNA purity. RNA purity of samples isolated from adult (n = 15 Tempus tubes/year) and cord (n =
6 Tempus tubes/year) blood samples collected in Tempus tubes and stored at –80°C until analysis using Nano Drop™. A) The OD 260/280 ratios
for adult and cord blood samples. B) The OD 260/230 ratios for adult and cord blood samples. Each bar represents the average OD-ratios and the
error bar indicates ± SE.
Duale et al. BMC Research Notes 2014, 7:633 Page 4 of 10
http://www.biomedcentral.com/1756-0500/7/633pronounced for CDKN1A, IL8 and MYC genes (Figure 4).
Furthermore, the IL1B and TP53 transcript levels were dif-
ferent than the other transcripts in year 1, but not in subse-
quent years. The reasons for the observed variable effects
of storage on RNA transcript stability are unclear. These
genes, CDKN1A, IL8 andMYC, had high average Cq-values
above 30, particularly for the cord blood samples, and the
corresponding low expression levels are expected to be as-
sociated with larger variability. Gene specific transcript sta-
bility may also be affected by secondary structure, and
possibly by the amplicon length and the distance of the
amplified region in regard to the polyadenylation site. The
amplicons lengths for the six genes are all similarly short
(66–107 bp) and the locations of the amplified regions were
close to 5′-terminus, except for IL1B. Nevertheless, the ob-
served transcript level changes were within ± 2–fold forboth types of blood samples, except for CDKN1A and
MYC gene at the 2-year storage time point (Figure 4).
We also investigated the variations in the raw non-
normalized Cq-values by calculating the coefficient of
variation (CV) of each gene after each storage year, i.e.,
mean Cq variations were established within a donor
(intra-donor) and between donors (inter-donor). Varia-
tions were also calculated across all storage years. The
non-normalized raw Cq and CV values for the six genes
are presented in Additional file 1 and Figure 5. From this
analysis, an overall picture of long-term storage effects on
transcript stability can be obtained. The differences in the
raw non-normalized Cq-values between stored and year 0
samples for each gene were small indicating low variability
(Additional file 1). For adult and cord blood samples, the
variations in the average Cq-values and CVs within a
Figure 3 Long-term storage effects on RNA integrity. RIN values for RNA samples isolated from Tempus tubes stored at –80°C until analyzed
by Agilent 2100 Bioanalyzer. RIN values for adult blood samples (n = 15 Tempus tubes/year) and RIN values for cord blood samples (n = 6 Tempus
tubes/year). Bars represent means ± SE. The average RIN values for adult and cord blood samples were 7.6 ± 0.5 and 7.7 ± 0.7, respectively, and no
significant long-term storage related effects on RNA integrity were observed.
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from 0.45% to 3.84% and from 0.12% to 4.74%, respect-
ively (Figure 5 and Additional file 1). Furthermore, the
variability (CV %) between donors (inter-donor) and be-
tween storage years was not higher than the variability
within a donor (intra-donor), reflecting the minor vari-
ation in expression of these genes (Figure 5). An interest-
ing finding was that samples from storage year 6 had a
narrower CV range than samples from the other years
(Figure 5); the reason for this is unclear. It has been re-
ported that mean CV values lower than 25% are typically
observed for stably expressed reference genes in relatively
homogeneous sample panels [17]. The calculated CV
values for stored samples were less than 5.0% for all sam-
ples indicating very low variability (Figure 5). The feasibil-
ity of detecting low abundant RNA transcripts in blood
samples collected in the Tempus tube was evaluated. Low
abundant transcripts, i.e., transcripts with Cq-values above
30 cycles, (CDKN1A, IL8 and MYC) were detected in all
analyzed samples (Additional file 1). Recently, mRNA tar-
gets have been detected with varying abundance levels
from blood sample collected in Tempus tubes without
globin mRNA reduction using qPCR assays [18]. The
interference of the high percentage of globin transcripts
from red blood cells (RBC) – which constitute ~70% of
the whole blood mRNA – may decrease the sensitivity of
detecting less abundant mRNA transcripts, particularly in
the microarray and Next-generation sequencing technolo-
gies [19,20]. The RBC globin mRNA transcripts in the
RNA population can be removed with an enzymatic deple-
tion using commercially available globin RNA reduction
kits, but this reaction reduced the quality of total RNAand is not always recommended [21]. Taken together, our
results demonstrate that RNA transcripts which are other-
wise highly sensitive to ex vivo conditions are efficiently
protected and remain stable during long-term storage in
Tempus tubes.
Conclusions
Blood cell RNA appears to be stable in Tempus tubes
stored for up to six years at –80°C. Intact and good-
quality RNA suitable for transcript profiling analyses in
epidemiological studies can be obtained from blood
samples stored in Tempus tubes. This suggests that
blood samples in large biobanks – such as the MoBa
Biobank at NIPH – and frozen in suitable collection
tubes for total RNA stabilization, can be used for quanti-
tative studies after several years of storage.
Methods
Sample collection and experimental design
Whole blood samples for RNA quality assessment were
collected from three healthy, consenting adult volunteers
among the NIPH staff and from the umbilical cord of
three newborns whose mothers had given their informed
consent to participate in MoBa. The samples were col-
lected into Tempus tubes (3 ml blood per tube) according
to the manufacturer’s instructions (Applied Biosystems,
Foster City, CA). For long-term storage QC, 170 Tempus
tubes were collected from three (A1, A2 and A3) adult
blood donors and 82 Tempus tubes from three (C4, C5
and C6) cord blood donors. The tubes were randomized
for each donor and labeled with unique numbers. The
adult blood samples were kept at ambient temperature for
Figure 4 Long-term storage effects on RNA transcript levels. The transcript levels for six genes were analyzed by RT-qPCR, using RNA
extracted from adult blood and cord blood samples collected in Tempus tubes stored at –80°C until analysis. A total of 21 Tempus Blood RNA
tubes (15 adult blood samples and 6 cord blood samples) were analyzed in each year. A) Relative transcript levels of six genes from adult blood
samples (n = 15 Tempus tubes/year). B) Relative transcript levels of six genes from cord blood samples (n = 6 Tempus tubes/year). The year 0
samples were used as reference (calibrators) and all other samples were compared against the reference samples. The dashed lines indicate ±
2-fold. Each bar represents the average log2-transformed fold change values and the error bar indicates ± SE.
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then transferred to –80°C for long-term storage. The cord
blood samples were shipped from a maternity unit at Ulle-
vål University Hospital at ambient temperature to NIPH
within one day but were otherwise handled in the same
way as samples from the adults. For each time point (year),
15 Tempus tubes containing adult blood from the three
donors (5 × 3) and six Tempus tubes containing cord
blood from the three donors (2 × 3) were analyzed; each
Tempus tube was considered as an independent biological
sample. The rational for this experimental design was to
establish a flexible protocol that was easy to follow but de-
tailed enough to correctly assess long-term storage effectson RNA quality. This QC study would run over several
years, probably involving different personnel and different
batches of kits. Therefore, it was important to collect
enough blood samples from each donor and analyze sev-
eral replicates from each donor at each time point in order
to control for donor-to-donor variations and variations
that may take place between phlebotomy and storage. Of
the 170 adult and 82 cord blood samples which were col-
lected in 2005, 75 Tempus tubes from three adult donors
and 30 tubes from three cord blood donors have so far
been analyzed. Since each Tempus tube was considered as
an independent biological sample, the analysis of in total
105 Tempus tubes should provide a good estimate on the
Figure 5 Variations in average Cq-values within and between donors. The coefficients of variation (CV) of the average Cq-values were
calculated for adult and cord blood samples collected in Tempus tubes and stored at –80°C until analysis for the expression of six genes. The CVs
within a donor (intra-donor) and between donors (inter-donor) across the storage years are presented. A) Adult blood samples. CVs ranged from
0.45% to 3.84%. B) Cord blood samples. CVs ranged from 0.12% to 4.74%. CV of 5% is indicated by a stippled line; CVs for all samples were
considerably lower reflecting minor variation in the average Cq-values. Each point represents the average CV of samples from one donor.
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The Regional Ethics Committee and the Data Inspectorate
approved the MoBa study, and participants gave their in-
formed consent.RNA extraction and QC
The samples were thawed overnight at 4°C before RNA
extraction the following day. Total RNA was extracted
using the Tempus 6-port RNA Isolation Kit Protocol
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Acid Prep Station according to manufacturer’s instruc-
tions, including DNase I treatment and addition of 1×
PBS adjusting the total volume to 12 ml prior to pro-
cessing (Applied Biosystems, Foster City, CA). An ali-
quot of 5 μl of each extracted total RNA was used for
RNA quality control assessments, while the remaining
RNA sample was stored at –80°C for later use.
The concentration of extracted total RNA was mea-
sured using NanoDrop ND-1000 spectrophotometer
(Fisher Scientific, Oslo, Norway). RNA purity was esti-
mated from the OD 260/280 and the OD 260/230 ratios.
The RNA integrity was assessed by an Agilent 2100
Bioanalyzer using the Eukaryote total RNA 6000 Nano
LabChip kit and Eukaryote total RNA Nano assay ac-
cording to the manufacturer’s instructions (Agilent
Technologies, Palo Alto, CA).
Quantitative Real-time PCR (RT-qPCR)
The cDNA was synthesized from 500 ng of total RNA
using the High Capacity cDNA Reverse Transcription Kit,
without RNase Inhibitor (Applied Biosystems). Reactions
were incubated in an Eppendorf MasterCycler (Eppendorf,
Hamburg, Germany) using the following incubation pro-
file: 10 minutes at 25°C, 2 hours at 37°C and finally, 5 mi-
nutes at 85°C. The cDNA quality was assessed using the
NanoDrop ND-1000, before storing the cDNA at –20°C.
Quantitative real-time PCR was performed in 96 well
PCR plates on a Fast 7500 Real Time PCR system (Ap-
plied Biosystems). Serial dilutions of cDNA were pre-
pared to determine an appropriate cDNA dilution.
A 1:10 dilution of cDNA was mixed with primers and
TaqMan® Fast Universal PCR Master Mix, No AmpErase
UNG, according to the manufacturer’s protocol (Applied
Biosystems). cDNA from each sample was run in tripli-
cate for each gene of interest. No template controls
(NTC) were included for each target gene in each run.
Transcript levels for the following six genes were measured,
applying commercial primers and probe assays from Ap-
plied Biosystems: CDKN1A (PN: Hs00355782_m1; ampli-
con size, 66 bp; assay location, 566; exon boundary, 2–3
exon), FOS (PN: Hs00170630_m1; amplicon size, 77 bp;
assay location, 352; exon boundary, 1–2 exon), IL1B (PN:
Hs00174097_m1; amplicon size, 94 bp; assay location, 554;
exon boundary, 5–6 exon), IL8 (PN: Hs00174103_m1;
amplicon size, 101 bp; assay location, 222; exon boundary,
1–2 exon), MYC (PN: Hs00153408_m1; amplicon size,
107 bp; assay location, 1325; exon boundary, 2–3 exon) and
TP53 (PN: Hs00153340_m1; amplicon size, 81 bp; assay lo-
cation, 173; exon boundary, 1–2 exon). 18S rRNA (PN:
Hs99999901_s1; amplicon size, 187 bp; assay location, 604;
exon boundary, 1–1 exon) was used as internal control.
These genes were selected based on our recent study [4]
and literature search [15,16] with varying mRNA transcriptabundance (from low to high abundant targets). Pooled
cDNA was included in each 96-well plate to allow for con-
trol of run-to-run variations (data not shown). The 7500
Fast PCR cycling program included an enzyme activation
step at 95°C for 20 seconds, and then 40 cycles of annealing
and extension steps at 95°C for 3 seconds and 60°C for
30 seconds, respectively.
Data analysis
The quantification cycle (Cq) values were recorded with
SDS v1.3 software (Applied Biosystems, Foster City,
CA); the Cq value is the fractional cycle number at
which the fluorescence exceeds a fixed threshold. The
raw Cq-values were then exported into Excel-files and
analyzed by the comparative Cq-method [22,23] using
18S rRNA as internal control. Prior to normalization,
the raw data (Cq-values) generated from qPCR experi-
ments were pre-processed to ensure that measurements
at low levels were well within the linear area of detec-
tion; Cq-values radically different from other technical
replicates were classified as outliers and excluded. The
excluded outliers were replaced by using the information
contained in the replicates when available. In addition,
all Cq-values above 35 were considered beyond the limit
of detection (LOD) and coded as missing values, because
Cq-values above 35 cycles are in general not reliable. Tar-
get genes were normalized to 18S rRNA internal controls,
[this is given by ΔCq; where ΔCq (sample) =Cq (target
gene) – Cq (internal controls)]. The ΔΔCq values were
generated by subtracting the ΔCq-value for the reference
samples (calibrators; year 0 samples) from the ΔCq-value
for the samples [ΔΔCq =ΔCq (sample) – ΔCq (calibrator);
fold change = 2-ΔΔCq]. The fold change values were then
log2-transformed in order to make the values symmetrical
around zero. The 18S rRNA stability was evaluated and
results are presented in Additional file 2.
Statistical analysis
Statistical analysis of RNA yield, purity, integrity and ΔCq-
values was carried out by one-way analysis of variance
(ANOVA), followed by post hoc Dunnett’s tests to allow
for multiple comparisons or by non-parametric Kruskal-
Wallis test. Normal distribution and equality of variances
were evaluated using the Shapiro-Wilk test and the
Levene’s test of homogeneity of variance. The data are
presented as means ± SE. Statistical analyses were per-
formed using SPSS v17 software (SPSS, Inc., Chicago, IL),
and results with p < 0.05 were accepted as statistically sig-
nificant. The coefficient of variation (CV) of the non-
normalized raw Cq-value for each gene was calculated by
dividing the mean Cq-value with the standard deviation.
CV, expressed as a percentage, was used for computing
the degree of variation in the mean Cq-values of the
stored samples.
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Additional file 1: The non-normalized raw Cq-values. The
non-normalized raw Cq-values for adult (three donors: A1, A2 and A3)
and cord blood (three donors: C4, C5 and C6) samples collected in the
Tempus tubes and stored for up to six years at −80°C; A) CDKN1A –
average Cq for adult blood samples was 31.20 ± 1.08 (28.61–33.23), while
for cord blood samples was 32.39 ± 1.17 (30.18–34.35); B) FOS – average
Cq for adult blood samples was 28.20 ± 0.89 (25.38–29.84), while for cord
blood samples was 28.75 ± 0.77 (26.72–30.31); C) IL1B – average Cq for
adult blood samples was 28.96 ± 0.92 (25.77–30.80), while for cord blood
samples was 29.68 ± 0.90 (26.38–31.79); D) IL8 – average for adult blood
samples Cq was 31.29 ± 0.67 (29.39–32.97), while for cord blood samples
was 32.46 ± 0.99 (30.18–34.66); E) MYC – average Cq for adult blood
samples was 29.53 ± 1.23 (26.14–31.81), while for cord blood samples was
30.62 ± 1.23 (27.78–33.41); F) TP53 – average Cq for adult blood samples
was 27.93 ± 1.05 (25.30–29.93), while for cord blood samples was 29.06 ±
0.72 (27.45–30.91). Each bar represents the average Cq-values and the
error bar indicates ± SD. G) Transcript abundance of the six genes.
Additional file 2: The evaluation of 18S rRNA stability. The stability
of 18S rRNA for adult and cord blood samples were evaluated, and the
raw Cq-values for 18S rRNA were relatively stable following the storage of
the tubes for up to six years at −80°C. A) Adult blood samples (three
donors: A1, A2 and A3); average Cq was 14.63 ± 0.51 and varied
(13.9–16.3) and B) cord blood samples (three donors: C4, C5 and C6);
average Cq was 14.92 ± 0.86 and varied (13.9–16.9). Each bar represents
the average Cq-values and the error bar indicates ± SD.
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